Influence of preservation solution on early graft failure in clinical lung transplantation

被引:69
作者
Thabut, G
Vinatier, I
Brugière, O
Lesèche, G
Loirat, P
Bisson, A
Marty, J
Fournier, M
Mal, H
机构
[1] Hop Beaujon, Serv Pneumol & Reanimat Resp, Clichy, France
[2] Hop Beaujon, Serv Chirurg Thorac & Vasc, Clichy, France
[3] Hop Beaujon, Serv Anesthesie & Reanimat, Clichy, France
[4] Hop Foch, Grp Transplantat Pulm, Suresnes, France
[5] Univ Paris 07, INSERM, U408, Paris, France
关键词
lung transplantation; organ preservation solutions; prognosis; reperfusion injury;
D O I
10.1164/ajrccm.164.7.2012135
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The aim of this study was to assess the influence of preservation solution type and extra- or intracellular composition on the occurrence of early graft dysfunction after clinical lung transplantation. For 170 patients who underwent a single (n = 124) or bilateral (n = 46) lung transplantation in two centers in Paris between 1988 and 1999, the preservation technique applied to the donor lung was single-flush perfusion of the pulmonary artery with one of several solutions of intracellular (Euro-Collins, n = 61; University of Wisconsin, n = 24) or extracellular composition (Cambridge, n = 64, Celsior, n = 21). The early postoperative outcome of these patients was reviewed. Reimplantation edema occurred in 48% of all patients, and the overall 1-mo survival rate was 84%. No significant difference in the incidence of edema, duration of mechanical ventilation, and 1-mo survival rate was observed between the four groups or between intra- and extracellular groups, After adjustment for graft ischemic time by means of multivariate analysis, the use of extracellular preservation fluid was associated with a lower incidence of reimplantation edema without effect on 1-mo mortality. Graft ischemic time was associated with both edema occurrence and 1-mo survival rate (p = 0.02 and p = 0.01, respectively). We conclude that extracellular-type solutions are associated with better lung preservation than intracellular-type solutions in clinical transplantation.
引用
收藏
页码:1204 / 1208
页数:5
相关论文
共 37 条
[1]   LUNG-TRANSPLANT EDEMA - CHEST RADIOGRAPHY AFTER LUNG TRANSPLANTATION - THE FIRST 10 DAYS [J].
ANDERSON, DC ;
GLAZER, HS ;
SEMENKOVICH, JW ;
PILGRAM, TK ;
TRULOCK, EP ;
COOPER, JD ;
PATTERSON, GA .
RADIOLOGY, 1995, 195 (01) :275-281
[2]   Medical progress - Lung transplantation [J].
Arcasoy, SM ;
Kotloff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) :1081-1091
[3]   Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation [J].
Bacha, EA ;
Herve, P ;
Murakami, S ;
Chapelier, A ;
Mazmanian, GM ;
deMontpreville, V ;
Detruit, H ;
Libert, JM ;
Dartevelle, P .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (03) :590-598
[4]   Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation [J].
Binns, OAR ;
DeLima, NF ;
Buchanan, SA ;
Cope, JT ;
King, RC ;
Marek, CA ;
Shockey, KS ;
Tribble, CG ;
Kron, IL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (06) :1515-1521
[5]  
BISSON A, 1992, J THORAC CARDIOV SUR, V103, P40
[6]   Primary graft failure following lung transplantation [J].
Christie, JD ;
Bavaria, JE ;
Palevsky, HI ;
Litzky, L ;
Blumenthal, NP ;
Kaiser, LR ;
Kotloff, RM .
CHEST, 1998, 114 (01) :51-60
[7]  
COOPER JD, 1987, J THORAC CARDIOV SUR, V93, P173
[8]  
HARDESTY RL, 1993, J THORAC CARDIOV SUR, V105, P660
[9]  
HENDRY PJ, 1993, J THORAC CARDIOV SUR, V105, P667
[10]  
Hopkinson DN, 1998, J HEART LUNG TRANSPL, V17, P525